1. Home
  2. ARQT vs RNST Comparison

ARQT vs RNST Comparison

Compare ARQT & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

SELL

Current Price

$27.14

Market Cap

3.3B

Sector

Health Care

ML Signal

SELL

RNST

Renasant Corporation

SELL

Current Price

$39.77

Market Cap

3.7B

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
ARQT
RNST
Founded
2016
1904
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.7B
IPO Year
2020
1999

Fundamental Metrics

Financial Performance
Metric
ARQT
RNST
Price
$27.14
$39.77
Analyst Decision
Buy
Buy
Analyst Count
8
7
Target Price
$40.38
★ $46.71
AVG Volume (30 Days)
★ 2.4M
680.9K
Earning Date
11-04-2026
10-27-2026
Dividend Yield
N/A
★ 2.39%
EPS Growth
★ 88.79
N/A
EPS
0.09
★ 2.74
Revenue
★ $376,072,000.00
N/A
Revenue This Year
$44.19
$11.46
Revenue Next Year
$29.31
$7.96
P/E Ratio
$314.67
★ $14.63
Revenue Growth
★ 91.34
N/A
52 Week Low
$19.30
$33.16
52 Week High
$34.80
$44.54

Technical Indicators

Market Signals
Indicator
ARQT
RNST
Relative Strength Index (RSI) 44.15 45.05
Support Level $25.08 $38.56
Resistance Level $28.54 $41.22
Average True Range (ATR) 1.58 1.17
MACD -0.48 -0.06
Stochastic Oscillator 19.64 55.24

Price Performance

Historical Comparison
ARQT
RNST

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has two reportable segments: Community banks and Wealth management. With its Community Banks segment, the company provides a range of financial services to individuals and small businesses. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

Share on Social Networks: